0JSY 주식 개요 랩코프 홀딩스는 실험실 서비스를 제공합니다. 자세한 내용
생각, 링크 및 회사 내러티브를 캡처하세요.
Labcorp Holdings Inc. 경쟁사 가격 내역 및 성능
다음에 대한 주가 최고가, 최저가 및 변동 요약 Labcorp Holdings 과거 주가 현재 주가 US$229.98 52주 최고치 US$248.07 52주 최저치 US$192.43 베타 1.04 1개월 변경 -3.79% 3개월 변경 사항 4.23% 1년 변경 사항 2.66% 3년 변화 -25.33% 5년 변화 37.30% IPO 이후 변화 30.37%
최근 뉴스 및 업데이트
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order Through Physicians Dec 18
Labcorp Holdings Inc. (NYSE:LH) completed the acquisition of Select Outreach Services of Ballad Health. Dec 13 Labcorp Holdings Inc. Announces Chief Financial Officer Changes
Upcoming dividend of US$0.72 per share Nov 19
Third quarter 2024 earnings released: EPS: US$2.02 (vs US$2.12 in 3Q 2023) Oct 25
Labcorp Holdings Inc. Updates Earnings Guidance for the Year 2024 Oct 24 더 많은 업데이트 보기
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order Through Physicians Dec 18
Labcorp Holdings Inc. (NYSE:LH) completed the acquisition of Select Outreach Services of Ballad Health. Dec 13 Labcorp Holdings Inc. Announces Chief Financial Officer Changes
Upcoming dividend of US$0.72 per share Nov 19
Third quarter 2024 earnings released: EPS: US$2.02 (vs US$2.12 in 3Q 2023) Oct 25
Labcorp Holdings Inc. Updates Earnings Guidance for the Year 2024 Oct 24 Labcorp Expands Sexually Transmitted Infection Test Offerings with Rapid Syphilis Test
Labcorp Holdings Inc. to Report Q3, 2024 Results on Oct 24, 2024 Sep 25
Labcorp Holdings Inc. (NYSE:LH) agreed to acquire 15% stake in SYNLAB AG (HMSE:SYAB) from Cinven Limited for €140 million. Sep 19
Laboratory Corporation of America Holdings (NYSE:LH) completed the acquisition of an Asset Purchase Agreement to acquire Select Assets of BioReference Health, LLC for approximately $240 million. Sep 17
Upcoming dividend of US$0.72 per share Aug 22
CFO & Executive VP recently sold US$3.4m worth of stock Aug 20
Insider recently sold US$2.8m worth of stock Aug 08
Laboratory Corporation of America Holdings (NYSE:LH) completed the acquisition of Substantially all Assets of Invitae Corporation (OTCPK:NVTA.Q). Aug 07
Labcorp Holdings Inc. Receives FDA De Novo Marketing Authorization for Pgdx Elio™ Plasma Focus Dx Aug 02
Second quarter 2024 earnings released: EPS: US$2.44 (vs US$1.75 in 2Q 2023) Aug 02
Labcorp Holdings Inc. Revises Financial Guidance for the Full Year 2024 Aug 01
Labcorp Declares Quarterly Cash Dividend, Payable on September 13, 2024 Jul 25
Labcorp Holdings Inc. to Report Q2, 2024 Results on Aug 01, 2024 Jul 02
Labcorp Launches Labcorp Global Trial Connect to Accelerate Clinical Trials Jun 18
Labcorp Holdings Inc. Announces New Strategic Service Offerings Within Precision Oncology Portfolio Jun 05
Upcoming dividend of US$0.72 per share May 17
Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk During Pregnancy May 16
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B Apr 30
First quarter 2024 earnings released: EPS: US$2.71 (vs US$2.35 in 1Q 2023) Apr 26
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation for approximately $240 million. Apr 26
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw Apr 15
Dividend of US$0.72 announced Apr 14 Labcorp Declares Quarterly Dividend, Payable on June 12, 2024
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs Apr 10 Laboratory Corporation of America Holdings, Annual General Meeting, May 14, 2024
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research Apr 02
Laboratory Corporation of America Holdings to Report Q1, 2024 Results on Apr 25, 2024 Mar 29
Laboratory Corporation of America Holdings to Report Q1, 2024 Results on Apr 25, 2024 Mar 28
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials Mar 20
Labcorp Launches Weight Loss Management Testing Solutions Mar 07
CFO & Executive VP recently sold US$4.4m worth of stock Feb 23
Upcoming dividend of US$0.72 per share Feb 19
Full year 2023 earnings released: EPS: US$4.35 (vs US$14.04 in FY 2022) Feb 16
Laboratory Corporation of America Holdings Announces Quarterly Cash Dividend, Payable on March 13, 2024 Feb 16
Labcorp Announces the Launch and Availability of A New, FDA-Cleared Blood Test for Risk Assessment and Clinical Management of Severe Preeclampsia Jan 31
Laboratory Corporation of America Holdings to Report Q4, 2023 Results on Feb 15, 2024 Jan 17
Labcorp Declares Quarterly Cash Dividend, Payable on March 13, 2024 Jan 12
Laboratory Corporation of America Holdings (NYSE:LH) completed the acquisition of Outreach laboratory business from Legacy Health System Insurance Company. Nov 21
Geneoscopy, Inc. Signs Multi-Year Agreement with Labcorp to Distribute Noninvasive Multi-Target Stool Rna (Mt-Srna) Colorectal Cancer Screening Test Nov 15
Upcoming dividend of US$0.72 per share at 1.5% yield Oct 31
Third quarter 2023 earnings released: EPS: US$2.12 (vs US$3.91 in 3Q 2022) Oct 27
Labcorp Declares a Cash Dividend, Payable on December 12, 2023 Oct 13
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Outreach Laboratory Business of Baystate Health, Inc. Oct 06
Laboratory Corporation of America Holdings to Report Q3, 2023 Results on Oct 26, 2023 Sep 30
Independent Director recently sold US$1.1m worth of stock Aug 11
Laboratory Corporation of America Holdings (NYSE:LH) entered into an agreement to acquire Outreach Laboratory Business and Select Operating Assets from Tufts Medicine, Inc. Aug 04
Upcoming dividend of US$0.72 per share at 1.3% yield Jul 31
Laboratory Corporation of America Holdings Announces Quarterly Cash Dividend, Payable on September 8, 2023 Jul 28
Second quarter 2023 earnings released: EPS: US$1.75 (vs US$3.89 in 2Q 2022) Jul 28
Laboratory Corporation of America Holdings acquired Clinical Laboratory Division from Enzo Biochem, Inc. for approximately $115 million. Jul 25
Laboratory Corporation of America Holdings (NYSE:LH) completed the acquisition of Outreach laboratory services assets of Jefferson Health. Jul 14
Laboratory Corporation of America Holdings (NYSE:LH) entered into an agreement to acquire Outreach laboratory business from Legacy Health System Insurance Company. Jul 12
Laboratory Corporation of America Holdings to Report Q2, 2023 Results on Jul 27, 2023 Jun 30
Laboratory Corporation of America Holdings Appoints Paul B. Rothman as a Member of the Board Jun 08
Laboratory Corporation of America Holdings Launches Labcorp Plasma Focus Jun 01
Laboratory Corporation of America Holdings (NYSE:LH) entered into an agreement to acquire the outreach laboratory business and select assets of Providence Health & Services - Oregon. May 17
Upcoming dividend of US$0.72 per share at 1.3% yield May 10 Laboratory Corporation of America Holdings Appoints Mark S. Schroeder to Executive Vice President, President Diagnostics & Chief Operations Officer
First quarter 2023 earnings released: EPS: US$2.41 (vs US$5.28 in 1Q 2022) Apr 26
Insider recently sold US$1.3m worth of stock Feb 24
Full year 2022 earnings released: EPS: US$14.04 (vs US$24.58 in FY 2021) Feb 17
Laboratory Corporation of America Holdings Provides Earnings Guidance for the Year 2023 Feb 17
Now 21% undervalued Feb 16
Upcoming dividend of US$0.72 per share at 1.2% yield Feb 15
Laboratory Corporation of America Holdings to Report Q4, 2022 Results on Feb 16, 2023 Jan 19
Labcorp Declares Cash Dividend on Common Stock, Payable on March 13, 2023 Jan 13
Labcorp Announces Executive Changes Jan 06
Upcoming dividend of US$0.72 per share Nov 09
Third quarter 2022 earnings released: EPS: US$3.91 (vs US$6.10 in 3Q 2021) Oct 27
Laboratory Corporation of America Holdings Appoints Kirsten Kliphouse to Board of Directors Oct 14
Labcorp Declares Quarterly Dividend, Payable on December 9, 2022 Oct 13
Laboratory Corporation of America Holdings (NYSE:LH) acquired Certain Outreach Laboratory Assets from Certain Outreach Laboratory Assets. Oct 04
Laboratory Corporation of America Holdings to Report Q3, 2022 Results on Oct 27, 2022 Sep 28
Laboratory Corporation of America Holdings (NYSE:LH) acquired Clinical Outreach Laboratory Business and Select Related Assets of RWJBarnabas Health. Aug 24
Upcoming dividend of US$0.72 per share Aug 10
Senior VP & Chief Accounting Officer recently sold US$467k worth of stock Aug 04
Second quarter 2022 earnings released: EPS: US$3.89 (vs US$4.80 in 2Q 2021) Jul 29
Laboratory Corporation of America Holdings Launches Labcorp Clinical Decision Support (CDS) interpretative test report for its Stinging Insect Component-Specific IgE Test Jul 20 Laboratory Corporation of America Holdings to Report Q2, 2022 Results on Jul 28, 2022
Labcorp to Begin Testing for Monkeypox Using the U.S. Centers for Disease Control and Prevention’s Othopoxvirus Test Jul 07 Labcorp Launches New Test for People with Skin Cancer Laboratory Corporation of America Holdings (NYSE:LH) acquired Select Assets from the Clinical Outreach Business of AtlantiCare. May 10
First quarter 2022 earnings released: EPS: US$5.28 (vs US$7.89 in 1Q 2021) Apr 29
Labcorp Launches Convenient Home Diagnostic Test Collection Service in Collaboration With Getlabs Apr 23 주주 수익률 0JSY GB Healthcare GB 마켓 7D -0.5% -0.05% -0.6% 1Y 2.7% -25.9% 3.1%
전체 주주 수익률 보기
수익률 대 산업: 0JSY 지난 1년 동안 -25.9 %를 반환한 UK Healthcare 산업을 초과했습니다.
수익률 대 시장: 0JSY 지난 1년 동안 3.1 %를 반환한 UK 시장과 일치했습니다.
가격 변동성 Is 0JSY's price volatile compared to industry and market? 0JSY volatility 0JSY Average Weekly Movement 2.9% Healthcare Industry Average Movement 5.0% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.6% 10% least volatile stocks in GB Market 2.6%
안정적인 주가: 0JSY 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.
시간에 따른 변동성: 0JSY 의 주간 변동성 ( 3% )은 지난 1년 동안 안정적인 모습을 보였습니다.
회사 소개 랩코프 홀딩스는 실험실 서비스를 제공합니다. 이 회사는 진단 실험실과 바이오 제약 실험실 서비스의 두 부문으로 운영됩니다. 이 회사는 혈액 화학 분석, 소변 검사, 혈구 수, 갑상선, PAP, 헤모글로빈 A1C 및 비타민 D, 전립선 특이 항원, 성병, C형 간염, 미생물 배양 및 절차, 알코올 및 기타 약물 남용 검사와 같은 다양한 검사를 제공합니다.
자세히 보기 Labcorp Holdings Inc. 기본 사항 요약 Labcorp Holdings 의 수익과 매출은 시가총액과 어떻게 비교하나요? 0JSY 기본 통계 시가총액 US$19.19b 수익(TTM ) US$435.50m 수익(TTM ) US$12.71b
수익 및 수익 최신 수익 보고서의 주요 수익성 통계(TTM) 0JSY 손익 계산서(TTM ) 수익 US$12.71b 수익 비용 US$9.16b 총 이익 US$3.55b 기타 비용 US$3.11b 수익 US$435.50m
주당 순이익(EPS) 5.21 총 마진 27.92% 순이익 마진 3.43% 부채/자본 비율 83.2%
0JSY 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기 기업 분석 및 재무 데이터 현황 데이터 마지막 업데이트(UTC 시간) 기업 분석 2024/12/25 21:30 장 마감 주가 2024/12/24 00:00 수익 2024/09/30 연간 수익 2023/12/31
데이터 소스 기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.
패키지 데이터 기간 미국 소스 예시 * 회사 재무 10년 애널리스트 컨센서스 추정치 +3년 시장 가격 30년 소유권 10년 관리 10년 주요 개발 사항 10년
* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.
명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.
분석 모델 및 눈송이 이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.
Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.
산업 및 부문 메트릭 업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.
애널리스트 출처 Labcorp Holdings Inc. 48 애널리스트 중 16 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.
분석가 교육기관 Jasper Hellweg Argus Research Company Brian Kemp Dolliver Avondale Partners Eric Coldwell Baird
45 더 많은 분석가 보기 
